Clinical trial
Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
NCT00064792 is registered in ClinicalTrials.gov with Forbes Porter, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
- Lead sponsor
- Forbes Porter, M.D.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- December 31, 2010
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.